ArticleClinical and translational medicine2023

Dynamic alterations of ctDNA associate with the therapeutic outcome in the advanced non-small cell lung cancer patients who received sintilimab plus anlotinib regime as 1st line therapy.

Tianqing Chu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.